{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T05:53:57Z","timestamp":1648965237610},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1002\/jps.24030","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T23:30:07Z","timestamp":1401233407000},"page":"2107-2115","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of Polycaprolactone Matrices for Sustained Vaginal Delivery of Nevirapine in the Prevention of Heterosexual HIV Transmission"],"prefix":"10.1016","volume":"103","author":[{"given":"Nhung","family":"Dang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haran","family":"Sivakumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Harrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Nicholas","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan G.A.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.24030_bb0010","year":"2013","journal-title":"UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2013."},{"key":"10.1002\/jps.24030_bb0015","year":"2010","journal-title":"Microbicide Trial Network. Understanding the results of CAPRISA 004."},{"issue":"11","key":"10.1002\/jps.24030_bb0020","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(08)70254-8","article-title":"Vaginal microbicides and the prevention of HIV transmission","volume":"8","author":"Cutler","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1002\/jps.24030_bb0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1471-2334-12-289","article-title":"Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: Systematic review and meta-analysis","volume":"12","author":"Obiero","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1002\/jps.24030_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/157016212799304625","article-title":"Non-specific microbicide product development: Then and now","volume":"10","author":"Romano","year":"2012","journal-title":"Curr HIV Res"},{"issue":"3","key":"10.1002\/jps.24030_bb0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.antiviral.2013.06.021","article-title":"Assessment of topical microbicides to prevent HIV-1 transmission: Concepts, testing, lessons learned","volume":"99","author":"Friend","year":"2013","journal-title":"Antiviral Res"},{"issue":"5996","key":"10.1002\/jps.24030_bb0040","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool","year":"2010","journal-title":"Science"},{"key":"10.1002\/jps.24030_bb0045","year":"2011","journal-title":"Microbicide Trial Network. MTN statement on decision to discontinue use of tenofovir gel in VOICE, a major HIV prevention study in women."},{"key":"10.1002\/jps.24030_bb0050","author":"Marrazzo","year":"2013"},{"issue":"1\u20132","key":"10.1002\/jps.24030_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2006.06.026","article-title":"Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide","volume":"325","author":"Woolfson","year":"2006","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1002\/jps.24030_bb0060","first-page":"62","article-title":"State of the art in intravaginal ring technology for topical prophylaxis of HIV infection","volume":"14","author":"Kiser","year":"2012","journal-title":"AIDS Rev"},{"issue":"5","key":"10.1002\/jps.24030_bb0065","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/jac\/dki326","article-title":"Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings","volume":"56","author":"Malcolm","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1002\/jps.24030_bb0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0885328212437393","article-title":"Development of intra-vaginal matrices from polycaprolactone for sustained release of antimicrobial agents","volume":"28","author":"Dang","year":"2013","journal-title":"J Biomater Appl"},{"issue":"10","key":"10.1002\/jps.24030_bb0075","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1002\/jps.23684","article-title":"An evaluation of polycaprolactone matrices for vaginal delivery of the antiviral, tenofovir, in preventing heterosexual transmission of HIV","volume":"102","author":"Dang","year":"2013","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1002\/jps.24030_bb0080","first-page":"690","article-title":"UV spectrophotometric method for the identification and solubility determination of nevirapine","volume":"64","author":"Stieger","year":"2009","journal-title":"Pharmazie"},{"key":"10.1002\/jps.24030_bb0085","first-page":"967","volume":"II","year":"2001","journal-title":"The Japanese Pharmacopoeia XIV"},{"issue":"2","key":"10.1002\/jps.24030_bb0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/jps.24030_bb0095","first-page":"A31","article-title":"Anti-HBV activity and intracellular metabolism of tenofovir in vitro","volume":"65","author":"Delaney","year":"2005","journal-title":"Antiviral Res"},{"issue":"10","key":"10.1002\/jps.24030_bb0100","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1021\/cg0704495","article-title":"Pseudopolymorphs and intrinsic dissolution of nevirapine","volume":"7","author":"Pereira","year":"2007","journal-title":"Cryst Growth Des"},{"issue":"0","key":"10.1002\/jps.24030_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0040-6031(94)01886-L","article-title":"A review of thermal methods used for the analysis of the crystal form, solution thermodynamics and glass transition behaviour of polyethylene glycols","volume":"248","author":"Craig","year":"1995","journal-title":"Thermochimica Acta"},{"issue":"2","key":"10.1002\/jps.24030_bb0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur J Pharm Sci"},{"issue":"2\u20133","key":"10.1002\/jps.24030_bb0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0168-3659(99)00083-8","article-title":"Mechanism of drug release from poly(L-lactic acid) matrix containing acidic or neutral drugs","volume":"60","author":"Miyajima","year":"1999","journal-title":"J Control Release"},{"issue":"2","key":"10.1002\/jps.24030_bb0120","doi-asserted-by":"crossref","first-page":"e4505","DOI":"10.1371\/journal.pone.0004505","article-title":"International network for comparison of HIV neutralization assays: The NeutNet report","volume":"4","author":"Fenyo","year":"2009","journal-title":"PloS One"},{"issue":"5","key":"10.1002\/jps.24030_bb0125","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/AAC.01313-07","article-title":"Entecavir exhibits inhibitory activity against human immunodeficiency virus under conditions of reduced viral challenge","volume":"52","author":"Lin","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.24030_bb0130","series-title":"Kucers' the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs","first-page":"3157","author":"Grayson","year":"2010"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915305281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915305281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T20:56:54Z","timestamp":1538600214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915305281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0022354915305281"],"URL":"https:\/\/doi.org\/10.1002\/jps.24030","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}